AMAnkur Mutreja

Ankur Mutreja

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ankur Mutreja has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Fahad Khokhar

    Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK

    3 shared publications
  • Gordon Dougan

    Affiliations Department of Medicine, Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), University of Cambridge, Cambridge, United Kingdom, The Wellcome Trust, London, United Kingdom

    2 shared publications
  • Jobin Jacob John

    Affiliation Department of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India

    2 shared publications
  • Junaid Iqbal

    Affiliation Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan

    2 shared publications
  • Zoe Anne Dyson

    Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK

    2 shared publications
  • Agila Kumari Pragasam

    Department of Clinical Microbiology, Christian Medical College, Vellore, India

    1 shared publication

Latest Publications

  • Open Access

    Evaluation of an SNP-Based Diagnostic Assay for Enteric Fever Detection in Resource-Limited Settings

    by Sadia Isfat Ara Rahman, Farhana Khanam, Fahad Khokhar, Zoe Dyson, Derek J. Pickard, Gordon Dougan, Ankur Mutreja, Firdausi Qadri

    The diagnosis of enteric fever has become difficult due to the nonspecific and overlapping clinical syndrome of typhoid and paratyphoid infections with other febrile illnesses. Moreover, the rapid emergence of fluoroquinolone-resistant typhoidal Salmonella and the lack of robust diagnostic methods highlight the urgent need for highly sensitive molecular techniques. Here, we evaluated the performance of a rapid, reliable, and cost-effective molecular diagnostic approach for detecting Salmonella Typhi, including the globally dominant haplotype H58 lineage (H58), and Salmonella Paratyphi A. An in-house-built conventional polymerase chain reaction (PCR) was performed on a collection of blood-culture-positive strains, and the sensitivity and specificity were compared with those of the standard blood culture results. H58 and non-H58 Typhi lineages with distinct resistance patterns were confirmed from the previously reported sequencing data. Our PCR result showed that target genes SSPA2308, STY2513, and STY0307 demonstrated 100% sensitivity and specificity for Salmonella Paratyphi A, Salmonella Typhi, and H58 Salmonella Typhi, respectively. The PCR assay reliably detected bacterial DNA at 5.2 × 104 colony-forming units (CFUs), with consistent amplification observed up to 10−1 dilution. This single-nucleotide polymorphism (SNP)-based diagnostic approach has added a new dimension to designing unique markers for multidrug-resistant (MDR)-associated H58 lineage detection and has the potential to inform local treatment algorithms.

  • Open Access

    Multiplex PCR assay to detect high risk lineages of Salmonella Typhi and Paratyphi A

    by Fahad Khokhar, Derek Pickard, Zoe Dyson, Junaid Iqbal, Agila Pragasam, Jobin Jacob John, Balaji Veeraraghavan, Farah Qamar, Gordon Dougan, Hilary MacQueen, et al.

    Enteric fever infections remain a significant public health issue, with up to 20 million infections per year. Increasing rates of antibiotic resistant strains have rendered many first-line antibiotics potentially ineffective. Genotype 4.3.1 (H58) is the main circulating lineage of S. Typhi in many South Asian countries and is associated with high levels of antibiotic resistance. The emergence and spread of extensively drug resistant (XDR) typhoid strains has increased the need for a rapid molecular test to identify and track these high-risk lineages for surveillance and vaccine prioritisation. Current methods require samples to be cultured for several days, followed by DNA extraction and sequencing to determine the specific lineage. We designed and evaluated the performance of a new multiplex PCR assay, targeting S. Paratyphi A as well as the H58 and XDR lineages of S. Typhi on a collection of bacterial strains. Our assay was 100% specific for the identification of lineage specific S. Typhi and S. Paratyphi A, when tested with a mix of non-Typhi Salmonella and non-Salmonella strains. With additional testing on clinical and environmental samples, this assay will allow rapid lineage level detection of typhoid of clinical significance, at a significantly lower cost to whole-genome sequencing. To our knowledge, this is the first report of a SNP-based multiplex PCR assay for the detection of lineage specific serovars of Salmonella Typhi.


  • Open Access

    Multiplex PCR Assay to Detect High Risk Lineages of Salmonella Typhi and Paratyphi A

    by Fahad A Khokhar, Derek Dj Pickard, Zoe A Dyson, Junaid Iqbal, Agila K Pragasam, Jobin Jacob John, Balaji Veeraraghavan, Farah N Qamar, Gordon Dougan, Hilary MacQueen, et al.

    Enteric fever infections remain a significant public health issue, with up to 20 million infections per year. Increasing rates of antibiotic resistant strains have rendered many first-line antibiotics potentially ineffective. Genotype 4.3.1 (H58) is the main circulating lineage of S . Typhi in many South Asian countries and is associated with high levels of antibiotic resistance. The emergence and spread of extensively drug resistant (XDR) typhoid strains has increased the need for a rapid molecular test to identify and track these high-risk lineages for surveillance and vaccine prioritisation. Current methods require samples to be cultured for several days, followed by DNA extraction and sequencing to determine the specific lineage. We designed and evaluated the performance of a new multiplex PCR assay, targeting S . Paratyphi A as well as the H58 and XDR lineages of S . Typhi on a collection of bacterial strains. Our assay was 100% specific for the identification of lineage specific S . Typhi and S . Paratyphi A, when tested with a mix of non-Typhi Salmonella and non- Salmonella strains. With additional testing on clinical and environmental samples, this assay will allow rapid lineage level detection of typhoid of clinical significance, at a significantly lower cost to whole-genome sequencing. To our knowledge, this is the first report of a SNP-based multiplex PCR assay for the detection of lineage specific serovars of Salmonella Typhi. Data Statement: All supporting data, code and protocols have been provided within the article or through supplementary data files.